The 66 rating InvestorsObserver gives to Corvus Pharmaceuticals Inc (CRVS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 71 percent of stocks in the Biotechnology industry, CRVS’s 66 overall rating means the stock scores better than 66 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
Is Corvus Pharmaceuticals Inc (CRVS) a Winner in the Biotechnology Industry?
Mentioned in this article
CRVS has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on CRVS!